White House says it will grab patents if companies set exorbitant prices for taxpayer-funded drugs

The Biden administration on Thursday said it will take control of patents for drugs that were developed with public funding but are priced too high, setting up another clash with the pharmaceutical industry.

Related Keywords

White House ,District Of Columbia ,United States ,Vermont ,America ,Bernard Sanders ,National Institutes Of Health ,Senate Health Committee ,Bayh Dole Act ,Pharmaceutical Research ,Health Committee Chairman Bernard Sanders ,National Institutes ,B Politics ,B Health Medical Pharma ,